1Tallman MS. New strategies for the treatment of acute myeloid leukemia including antibodies and other lovel agents [ J]. Hematology ,2005,10 : 143-150.
2Grimwade D,Walker H,Oliver F,et al. The importance of diagnostic cytogenetics on outcome in AML-analysis of 1, 612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties[ J]. Blood, 1998,92:2322-2333.
4Slovak ML, Kopecky KJ, Cassileth PA,et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia:a Southwest Oncology Group/Eastern Cooperative Oncology Group Study [ J].Blood ,2000,96:4075-4083.
5Sanz MA,Martin G,Gonzalez M,et al. Risk-adapted treamtment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group[ J]. Blood,2004,103 : 1237- 1243.
6Rowe JM, Neuberg D, Friedenberg W, et al. A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group [ J ]. Blood, 2004,103 :479- 485.
7Anderson JE, Kopecky KJ,Willman CL,et al. Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to eytarabine and daunorubiein-a Southwest Oneology Group study [ J]. Blood ,2002,100:3869-3876.
8Mayer R J, Davis RB, Schiffer CA,et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia.Cancer and Leukemia Group[J]. N Engl J Med,1994,331.896 -903.
9Meloni G, Diverlo D, Vignetti M ,et al. Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene[ J].Blood, 1997,90 : 1321-1325.
10Linker CA, Ries CA, Damon LE, et al. Autologous stem cell transplantation for acute myeloid leukemia in first remission [ J]. Biol Blood Marrow Transplant ,2000,6:50-57.
